Additional file 4 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

Additional file 4 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

Additional file 4: Figure S4. No change in the mouse body weight between control and treated groups throughout the treatment. No impact of bufalin on the organ/body weight ratio (p>0.05).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Soumoy, Laura, Genbauffe, Aline, Mouchart, Lena, Sperone, Alexandra, Trelcat, Anne, Mukeba-Harchies, Léa, Wells, Mathilde, Blankert, Bertrand, Najem, Ahmad, Ghanem, Ghanem, Saussez, Sven, Journe, Fabrice
Format: Bild
Sprache:eng
Schlagworte:
Biological Sciences not elsewhere classified
Biotechnology
Cancer
Cell Biology
Developmental Biology
Hematology
Medicine
Molecular Biology
Pharmacology
Space Science
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Additional file 4: Figure S4. No change in the mouse body weight between control and treated groups throughout the treatment. No impact of bufalin on the organ/body weight ratio (p>0.05).
DOI:10.6084/m9.figshare.26660837